Skip to main content
SpringerLink
Log in

Bessere Prognose von Low-grade-Gliomen durch Kombination von Bestrahlung, Procarbazin, CCNU und Vincristin

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Buckner JC, Shaw EG, Pugh SL et al (2016) Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma. N Engl J Med 374(14):1344–1355. doi:10.1056/NEJMoa1500925

    Article  CAS  PubMed  Google Scholar 

  2. Bent MJ van den et al (2013) Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol 31(3):344–350

    Article  PubMed  Google Scholar 

  3. Bent MJ van den et al (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366(9490):985–990

    Article  PubMed  Google Scholar 

  4. Cairncross G et al (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 31(3):337–343

    Article  CAS  PubMed  Google Scholar 

  5. Prabhu RS et al (2014) Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02. J Clin Oncol 32(6):535–541

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wick W et al (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27(35):5874–5880

    Article  CAS  PubMed  Google Scholar 

  7. Wiestler B et al (2014) Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial. Neuro-oncology 16(12):1630–1638

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Innovative Radiotherapie (iRT) Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764, Oberschleißheim, Deutschland

    Stephanie E. Combs

  2. Klinik und Poliklinik für RadioOnkologie und Strahlentherapie, Technische Universität München, Klinikum rechts der Isar, Ismaninger Straße 22, 81675, München, Deutschland

    Stephanie E. Combs

  3. Klinik für Neurologie, Technische Universität München, Klinikum rechts der Isar, Ismaninger Straße 22, 81675, München, Deutschland

    Friederike Schmidt-Graf

  4. Klinik für Neurochirurgie, Technische Universität München, Klinikum rechts der Isar, Ismaninger Straße 22, 81675, München, Deutschland

    Bernhard Meyer

Authors
  1. Stephanie E. Combs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Friederike Schmidt-Graf
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bernhard Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephanie E. Combs.

Ethics declarations

Interessenkonflikt

S. E. Combs, F. Schmidt-Graf und B. Meyer geben an, dass kein Interessenkonflikt besteht.

Additional information

Originalpublikation Buckner JC, Shaw EG, Pugh SL et al (2016) Radiation plus Procarbazine, CCNU, and Vincristine in low-grade glioma. N Engl J Med 374(14):1344–1355. doi:10.1056/NEJMoa1500925

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Combs, S.E., Schmidt-Graf, F. & Meyer, B. Bessere Prognose von Low-grade-Gliomen durch Kombination von Bestrahlung, Procarbazin, CCNU und Vincristin . Strahlenther Onkol 192, 672–674 (2016). https://doi.org/10.1007/s00066-016-1016-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-016-1016-6

Search

Navigation